1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Atrophy Global Clinical Trials Review, H1, 2014

Atrophy Global Clinical Trials Review, H1, 2014

  • February 2014
  • -
  • Global Data
  • -
  • 108 pages

Atrophy Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Atrophy Global Clinical Trials Review, H1, 2014" provides data on the Atrophy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrophy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atrophy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Atrophy Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Atrophy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Atrophy to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Atrophy to Dermatology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Atrophy 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Atrophy Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Othera Pharmaceuticals, Inc. 31
Clinical Trial Overview of Othera Pharmaceuticals, Inc. 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Karo Bio AB 33
Clinical Trial Overview of Karo Bio AB 33
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
SBI Biotech Co., Ltd. 35
Clinical Trial Overview of SBI Biotech Co., Ltd. 35
Laboratoires Pierre Fabre SA 36
Clinical Trial Overview of Laboratoires Pierre Fabre SA 36
Juvantia Pharma Oy 37
Clinical Trial Overview of Juvantia Pharma Oy 37
Chelsea Therapeutics International Ltd. 38
Clinical Trial Overview of Chelsea Therapeutics International Ltd. 38
Biogen Idec Inc. 39
Clinical Trial Overview of Biogen Idec Inc. 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Clinical Trial Overview of Top Institutes / Government 41
Vanderbilt University 41
Clinical Trial Overview of Vanderbilt University 41
Maastricht University Medical Center 42
Clinical Trial Overview of Maastricht University Medical Center 42
National Eye Institute 43
Clinical Trial Overview of National Eye Institute 43
University Hospital, Toulouse 44
Clinical Trial Overview of University Hospital, Toulouse 44
University of Sao Paulo 45
Clinical Trial Overview of University of Sao Paulo 45
Federal University of Sao Paulo 46
Clinical Trial Overview of Federal University of Sao Paulo 46
National Institute of Neurological Disorders and Stroke 47
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 47
University of Massachusetts 48
Clinical Trial Overview of University of Massachusetts 48
Glostrup University Hospital 49
Clinical Trial Overview of Glostrup University Hospital 49
University Hospital, Bordeaux 50
Clinical Trial Overview of University Hospital, Bordeaux 50
Five Key Clinical Profiles 51
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 108

List of Tables
Atrophy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Atrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Atrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Atrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Atrophy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Atrophy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Atrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Atrophy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Atrophy to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Atrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Atrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Atrophy to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Atrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Atrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Atrophy Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Atrophy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Atrophy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Atrophy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Atrophy Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Atrophy Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Atrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Atrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Atrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Atrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Atrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Othera Pharmaceuticals, Inc., 2014* 31
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 32
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Karo Bio AB, 2014* 33
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 34
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by SBI Biotech Co., Ltd., 2014* 35
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014* 36
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Juvantia Pharma Oy, 2014* 37
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chelsea Therapeutics International Ltd., 2014* 38
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 39
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 40
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 41
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 42
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 43
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2014* 44
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 45
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2014* 46
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 47
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2014* 48
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2014* 49
Atrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014* 50

List of Figures
Atrophy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Atrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Atrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Atrophy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Atrophy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Atrophy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Atrophy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Atrophy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Atrophy to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Atrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Atrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Atrophy to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Atrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Atrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Atrophy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Atrophy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Atrophy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Atrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Atrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Atrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Atrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Atrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 107

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.